# Vincent A. Restivo – FDA Inspection, May 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/vincent-a-restivo/64d62502-739e-4245-9825-9a63eeb4a84e
Source feed: FDA_Inspections

> FDA inspection 1207133 of Vincent A. Restivo, May 26, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207133
- Company Name: Vincent A. Restivo
- Inspection Date: 2023-05-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)
- [Issuing Officer](https://www.keypedia.com/people/iris-c-macinnes/5e8d7fef-18d5-453d-82b2-19e8e2897d26)

Company: https://www.keypedia.com/companies/vincent-a-restivo/b988678f-31e5-454c-8217-6b5258f5bf61

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c